Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DESPIAD trial of CPHPC in mild Alzheimer's disease
2016-003284-19Phase 2Unknown
- Sponsor
- University College London
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing CPHPC with Placebo (2 arms). Primary endpoint: Safety and tolerability of CPHPC. Status: unknown.
02
Drugs
miridesap
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2016-003284-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003284-19.